We are live on
!
Find out more
IB
Intrust Bank Portfolio holdings
AUM
$1.35B
Turnover
12.1%
1-Year Est. Return
37.16%
This Fund
S&P 500
This Quarter
Est. Return
-4.63%
1 Year Est. Return
+37.16%
3 Year Est. Return
+102.36%
5 Year Est. Return
+128.73%
10 Year Est. Return
+460.32%
AUM
$649M
AUM Growth
-$43.1M
(-6.2%)
Cap. Flow
-$5.39M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
398
New
15
Increased
159
Reduced
174
Closed
32
Avg Time Held
4.9
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$6.61M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.16M |
| 3 |
CrossFirst Bankshares, Inc. Common Stock
CFB
|
+$1.58M |
| 4 |
Tesla
TSLA
|
+$573K |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$484K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.08M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$2M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.5M |
| 4 |
Advanced Micro Devices
AMD
|
+$1.17M |
| 5 |
JMIN
JPMorgan U.S. Minimum Volatility ETF
JMIN
|
+$800K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.45% |
| 2 | Technology | 12.14% |
| 3 | Healthcare | 10.64% |
| 4 | Financials | 8.32% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Vanguard Morningstar Large-Cap ETF
VV
$54.6B
| $4.35M | 0.67% |
26,588
-205
| -0.8% | -$37.3K |
2020 Q3
8 quarters
|
|
|
27
Tesla
TSLA
$1.42T
| $4.3M | 0.66% |
16,205
+2,051
| +14% | +$573K |
2020 Q3
8 quarters
|
|
28
Berkshire Hathaway Class A
BRK.A
$1.13T
| $4.07M | 0.63% |
10
| – | – |
2013 Q2
37 quarters
|
|
29
NextEra Energy
NEE
$165B
| $4.02M | 0.62% |
51,236
+965
| +2% | +$81.9K |
2013 Q2
37 quarters
|
|
30
Johnson & Johnson
JNJ
$620B
| $3.92M | 0.6% |
23,964
-722
| -3% | -$122K |
2013 Q2
37 quarters
|
|
31
ExxonMobil
XOM
$720B
| $3.89M | 0.6% |
44,590
-978
| -2% | -$89.3K |
2013 Q2
37 quarters
|
|
32
Visa
V
$750B
| $3.63M | 0.56% |
20,425
-1,401
| -6% | -$285K |
2013 Q2
37 quarters
|
|
33
Thermo Fisher Scientific
TMO
$256B
| $3.23M | 0.5% |
6,372
-248
| -4% | -$139K |
2013 Q2
37 quarters
|
|
34
Home Depot
HD
$304B
| $3.16M | 0.49% |
11,462
-149
| -1% | -$44K |
2013 Q2
37 quarters
|
|
35
Broadridge
BR
$19.7B
| $3.04M | 0.47% |
21,055
-76
| -0.4% | -$12.3K |
2013 Q2
37 quarters
|
|
36
AbbVie
ABBV
$510B
| $3.02M | 0.47% |
22,488
-1,053
| -4% | -$151K |
2013 Q2
37 quarters
|
|
37
Union Pacific
UNP
$171B
| $3.02M | 0.46% |
15,479
+554
| +4% | +$123K |
2013 Q2
37 quarters
|
|
|
38
iShares MSCI USA Momentum Factor ETF
MTUM
$18.9B
| $2.98M | 0.46% |
22,731
-14,229
| -38% | -$2M |
2020 Q2
9 quarters
|
|
39
Pfizer
PFE
$170B
| $2.87M | 0.44% |
65,476
-4,997
| -7% | -$243K |
2013 Q2
37 quarters
|
|
40
Merck
MRK
$369B
| $2.75M | 0.42% |
31,917
+198
| +0.6% | +$17.7K |
2013 Q2
37 quarters
|
|
41
Prologis
PLD
$121B
| $2.43M | 0.37% |
23,872
-510
| -2% | -$63.3K |
2015 Q3
28 quarters
|
|
42
Abbott
ABT
$181B
| $2.4M | 0.37% |
24,753
-1,025
| -4% | -$109K |
2013 Q2
37 quarters
|
|
43
IDEX
IEX
$17.3B
| $2.39M | 0.37% |
11,960
+257
| +2% | +$52K |
2013 Q2
37 quarters
|
|
44
JPMorgan US Momentum Factor ETF
JMOM
$2.7B
| $2.38M | 0.37% |
67,581
+5,114
| +8% | +$198K |
2020 Q2
9 quarters
|
|
45
Broadcom
AVGO
$1.62T
| $2.34M | 0.36% |
52,770
+1,150
| +2% | +$58.8K |
2015 Q3
28 quarters
|
|
46
McDonald's
MCD
$172B
| $2.33M | 0.36% |
10,079
+93
| +0.9% | +$23.8K |
2013 Q2
37 quarters
|
|
47
Synopsys
SNPS
$89B
| $2.25M | 0.35% |
7,379
+238
| +3% | +$80.6K |
2016 Q2
25 quarters
|
|
48
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.3B
| $2.22M | 0.34% |
71,575
+10,031
| +16% | +$341K |
2018 Q4
15 quarters
|
|
49
NVIDIA
NVDA
$5.23T
| $2.2M | 0.34% |
181,340
-34,420
| -16% | -$544K |
2017 Q3
20 quarters
|
|
50
Procter & Gamble
PG
$367B
| $2.19M | 0.34% |
17,347
-205
| -1% | -$29.1K |
2013 Q2
37 quarters
|
|
Similar funds
CC
HVCM
RI
RCYC
KB
NC
PP
OPFM
Intrust Bank's Q3 2022 Portfolio in Review
As of Q3 2022, Intrust Bank held 398 positions worth $649M, down 6.2% from $692M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Intrust Bank's Q3 2022 filing shows 15 new, 159 increased, 174 reduced and 32 closed positions. Its largest new stake was CrossFirst Bankshares, Inc. Common Stock: 116,268 shares worth $1.52M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $6.08M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 41% a quarter earlier, followed by Technology and Healthcare.
- Intrust Bank's largest Q3 2022 buy was CrossFirst Bankshares, Inc. Common Stock: 116,268 shares worth $1.52M.
- Intrust Bank added most to Vanguard Morningstar Mid-Cap ETF in Q3 2022, an estimated $6.61M increase.
- Intrust Bank's biggest Q3 2022 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $6.08M.
- Intrust Bank fully exited JPMorgan U.S. Minimum Volatility ETF in Q3 2022, selling an estimated $800K.
- Intrust Bank's ten largest holdings make up 40% of its $649M portfolio in Q3 2022.
- Intrust Bank opened 15 new positions and closed 32 in Q3 2022.
- Intrust Bank's portfolio value fell 6.2% quarter-over-quarter to $649M.
Based on Intrust Bank's 13F filing for Q3 2022, filed 9 Nov 2022.